To confirm the mTORC1 dependence of rpS6 S235/236 phosphorylation in AML cells, we first incubated cells with rapamycin with and without the MEK (ERK pathway) inhibitor U0126 in KG1a cells and measured p-mTOR and p-rpS6. The gene discussed is RPS6; the disease is acute myeloid leukemia.